Breaking Finance News

MetLife (NYSE:MET) stock price target increased to $58.00, issued a research note today by FBR & Co.

Yesterday MetLife (NYSE:MET) traded 0.84% higher at $50.52. The company’s 50-day moving average is $49.14 and its 200-day moving average is $47.66. The last stock close price is up 11.25% from the 200-day moving average, compared to the S&P 500 which has increased 0.02% over the same time. 5,112,059 shares of the stock were exchanged, down from an average trading volume of 5,540,240

In a report released on 05/25/2017 FBR & Co. increased the stock price target of MetLife (NYSE:MET) to $58.00 indicating a possible upside of 0.15%.

See Chart Below

MetLife (NYSE:MET)

MetLife has a 52 week low of $40.30 and a 52 week high of $53.27 with a P/E ratio of 623.76 MetLife’s market capitalization is currently $0.

In addition to FBR & Co. reporting its stock price target, a total of 14 brokerages have issued a ratings update on the company. The average stock price target is $49.71 with 5 brokerages rating the stock a strong buy, 6 brokerages rating the stock a buy, 6 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On MetLife (NYSE:MET)

MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *